Skip to main content

Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer

  • The original article was published in Journal for ImmunoTherapy of Cancer 2017 5:39

Erratum

After publication of this article [1], it was noticed that Table 3 contained errors introduced during the production process. The corrected Table 3 can be seen below and the original article has been updated to correct the errors.

Table 3 Multivariate Cox proportional hazard analysis for DFS and OS of patients with non-mesastatic invasive breast cancer

Reference

  1. 1.

    Fortis, S. P., Sofopoulos, M., Sotiriadou, N. N., Haritos, C., Vaxevanis, C. K., Anastasopoulou, E. A., … Baxevanis, C. N. Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. J Immunother Cancer. 2017, 5, 39. http://doi.org/10.1186/s40425-017-0240-7.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Sonia A. Perez.

Additional information

The online version of the original article can be found under doi:10.1186/s40425-017-0240-7.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fortis, S.P., Sofopoulos, M., Sotiriadou, N.N. et al. Erratum to: Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer. j. immunotherapy cancer 5, 48 (2017). https://doi.org/10.1186/s40425-017-0248-z

Download citation